Compare STNG & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STNG | TXG |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2010 | 2019 |
| Metric | STNG | TXG |
|---|---|---|
| Price | $63.21 | $20.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $70.17 | $16.18 |
| AVG Volume (30 Days) | 1.1M | ★ 2.7M |
| Earning Date | 02-12-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.88 | N/A |
| Revenue | ★ $889,539,000.00 | $641,814,000.00 |
| Revenue This Year | N/A | $4.94 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.82 | ★ N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $30.63 | $6.78 |
| 52 Week High | $65.52 | $23.56 |
| Indicator | STNG | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 67.42 | 50.80 |
| Support Level | $57.00 | $19.34 |
| Resistance Level | $60.51 | $23.56 |
| Average True Range (ATR) | 2.16 | 1.31 |
| MACD | 0.69 | -0.22 |
| Stochastic Oscillator | 93.55 | 33.17 |
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).